1. Home
  2. NRC vs ENTA Comparison

NRC vs ENTA Comparison

Compare NRC & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$22.29

Market Cap

428.2M

Sector

Health Care

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.70

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
ENTA
Founded
1981
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.2M
486.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NRC
ENTA
Price
$22.29
$12.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
79.3K
368.3K
Earning Date
02-10-2026
02-09-2026
Dividend Yield
2.88%
N/A
EPS Growth
N/A
N/A
EPS
0.71
N/A
Revenue
$139,102,000.00
$65,324,000.00
Revenue This Year
N/A
$0.99
Revenue Next Year
N/A
$0.19
P/E Ratio
$31.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.76
$4.09
52 Week High
$22.29
$17.15

Technical Indicators

Market Signals
Indicator
NRC
ENTA
Relative Strength Index (RSI) 77.06 39.08
Support Level $18.43 $14.07
Resistance Level $19.38 $13.98
Average True Range (ATR) 0.85 0.84
MACD 0.20 -0.28
Stochastic Oscillator 99.08 4.30

Price Performance

Historical Comparison
NRC
ENTA

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: